Cribriform-morular variant of thyroid carcinoma: a neoplasm with distinctive phenotype associated with the activation of the WNT/β-catenin pathway.
José Manuel Cameselle-TeijeiroDiego Peteiro-GonzálezJavier Caneiro-GómezMaría Sánchez-AresIhab AbdulkaderCatarina EloyMiguel MeloIsabel AmendoeiraPaula SoaresManuel Sobrinho-SimõesPublished in: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc (2018)
Cribriform-morular variant of thyroid carcinoma is classically associated with familial adenomatous polyposis but, it can also occur as a sporadic neoplasm. This neoplasm is much more frequently observed in women than in men (ratio of 61:1). In familial adenomatous polyposis patients, tumors are generally multifocal and/or bilateral (multinodular appearance), whereas in the sporadic cases tumors tend to occur as single nodules. The tumors are well delimited, and characteristically show a blending of follicular, cribriform, papillary, trabecular, solid, and morular patterns. Neoplastic cells are tall or cuboidal with the occasional nuclear features of classic papillary thyroid carcinoma. The morules include cells with peculiar nuclear clearing and show positivity for CDX2 and CD10. Angioinvasion and capsular invasion have been described in about 30 and 40% of cases, respectively, with lymph node metastases in less than 10% of patients and distant metastases in 6%. Although this tumor has good prognosis, neuroendocrine and/or poor differentiation have been associated with aggressive behavior. Tumor cells can be focally positive or negative for thyroglobulin, but are always positive for TTF-1, estrogen and progesterone receptors, and negative for calcitonin and cytokeratin 20. Nuclear and cytoplasmic staining for β-catenin is the hallmark of this tumor type; this feature plays a role in fine needle aspiration biopsy. Cribriform-morular variant of thyroid carcinoma has a peculiar endodermal (intestinal-like) type phenotype, activation of the WNT/β-catenin signaling pathway, and belongs to the non-BRAF-non-RAS subtype of the molecular classification of thyroid tumors. Elevated expression of estrogen and progesterone receptors and activation of the WNT/β-catenin pathway may prove useful as putative therapeutic targets in cases that do not respond to conventional therapy. Clinicians should be alerted to the possibility of familial adenomatous polyposis when a diagnosis of cribriform-morular variant of thyroid carcinoma is made. Instead of being considered as a variant of papillary thyroid carcinoma its designation as cribriform-morular thyroid carcinoma seems more appropriate.
Keyphrases
- lymph node
- end stage renal disease
- fine needle aspiration
- cell proliferation
- newly diagnosed
- ejection fraction
- induced apoptosis
- stem cells
- chronic kidney disease
- early onset
- peritoneal dialysis
- estrogen receptor
- ultrasound guided
- deep learning
- machine learning
- low grade
- late onset
- oxidative stress
- palliative care
- lymph node metastasis
- adipose tissue
- pregnant women
- neoadjuvant chemotherapy
- bone mineral density
- metabolic syndrome
- cell death
- endoplasmic reticulum stress
- long non coding rna
- pregnancy outcomes
- bone marrow
- signaling pathway
- high grade
- binding protein
- insulin resistance
- postmenopausal women
- polycystic ovary syndrome